Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation.
Comments Off on Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation.
April 27, 2026
A new preclinical study demonstrates that CBD glioblastoma prevention may be possible through extended pretreatment in mice. While promising, this early research requires extensive human studies before any clinical applications. Dr. Caplan explains what…
Cannabidiol: Attenuation of Behavioral and Cognitive Schizophrenia Symptoms Leads to Potential Clinical Applications
Comments Off on Cannabidiol: Attenuation of Behavioral and Cognitive Schizophrenia Symptoms Leads to Potential Clinical Applications
March 9, 2021
Cannabidiol antipsychotic effects schizophrenia research reveals CBD's ability to reduce behavioral and cognitive symptoms in a rodent model. The study highlights the role of the 5-HT1A receptor in these therapeutic effects. These findings suggest…